Authors: Post, RM Nolen, WA Kupka, RW Denicoff, KD Leverich, GS Keck, PE McElroy, SL Rush, AJ Suppes, T Altshuler, LL Frye, MA Grunze, H Walden, J

Citation: Rm. Post et al., The Stanley Foundation Bipolar Network I. Rationale and methods, BR J PSYCHI, 178, 2001, pp. S169-S176

Authors: Kupka, RW Nolen, WA Altshuler, LL Denicoff, KD Frye, MA Leverich, GS Keck, PE McElroy, SL Rush, AJ Suppes, T Post, RM

Citation: Rw. Kupka et al., The Stanley Foundation Bipolar Network 2. Preliminary summary of demographics, course of illness and response to novel treatments, BR J PSYCHI, 178, 2001, pp. S177-S183

Authors: McElroy, SL Altshuler, LL Suppes, T Keck, PE Frye, MA Denicoff, KD Nolen, WA Kupka, RW Leverich, GS Rochussen, JR Rush, AJ Post, RM

Citation: Sl. Mcelroy et al., Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder, AM J PSYCHI, 158(3), 2001, pp. 420-426

Authors: McElroy, SL Suppes, T Keck, PE Frye, MA Denicoff, KD Altshuler, LL Brown, ES Nolen, WA Kupka, RW Rochussen, J Leverich, GS Post, RM

Citation: Sl. Mcelroy et al., Open-label adjunctive topiramate in the treatment of bipolar disorders, BIOL PSYCHI, 47(12), 2000, pp. 1025-1033